Manipulating the anabolic and catabolic response in bone graft remodeling: Synergism by a combination of local BMP‐7 and a single systemic dosis of zoledronate
暂无分享,去创建一个
[1] A. Schindeler,et al. The anabolic and catabolic responses in bone repair. , 2007, The Journal of bone and joint surgery. British volume.
[2] P. Aspenberg,et al. Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling. A bone chamber study in rats , 2006, BMC Musculoskeletal Disorders.
[3] H. Yoshikawa,et al. Bone Morphogenetic Proteins in Bone Stimulate Osteoclasts and Osteoblasts During Bone Development , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] J. Kärrholm,et al. Mixing bone graft with OP-1 does not improve cup or stem fixation in revision surgery of the hip: 5-year follow-up of 10 acetabular and 11 femoral study cases and 40 control cases , 2006, Acta orthopaedica.
[5] P. Aspenberg,et al. Systemic zoledronate precoating of a bone graft reduces bone resorption during remodeling , 2006, Acta orthopaedica.
[6] N. Amanat,et al. Manipulation of the Anabolic and Catabolic Responses With OP‐1 and Zoledronic Acid in a Rat Critical Defect Model , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[7] Lynne E Bilston,et al. A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[8] H. Rubash,et al. Osteoblast proliferation and maturation by bisphosphonates. , 2004, Biomaterials.
[9] M. Rogers. New insights into the molecular mechanisms of action of bisphosphonates. , 2003, Current pharmaceutical design.
[10] P. Aspenberg,et al. A combination of bisphosphonate and BMP additives in impacted bone allografts , 2003, Acta orthopaedica Scandinavica.
[11] P. Aspenberg,et al. No augmentation of morselized and impacted bone graft by OP-1 in a weight-bearing model , 2003, Acta orthopaedica Scandinavica.
[12] S. Santavirta,et al. Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients , 2002, The Journal of bone and joint surgery. American volume.
[13] P. Aspenberg,et al. Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats , 2002, BMC musculoskeletal disorders.
[14] G. Zych,et al. Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions: A Prospective, Randomized Clinical Trial Comparing rhOP-1 with Fresh Bone Autograft* , 2001, The Journal of bone and joint surgery. American volume.
[15] M. Kumegawa,et al. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. , 2000, Bone.
[16] P. Aspenberg,et al. Bone Graft Incorporation: Effects of Osteogenic Protein-1 and Impaction , 2000, Clinical orthopaedics and related research.
[17] E. Salvati,et al. Enhancement of Bone Formation in the Setting of Repeated Tissue Deformation , 1998, Clinical orthopaedics and related research.
[18] K. Chihara,et al. Stimulatory effect of bone morphogenetic protein‐2 on osteoclast‐like cell formation and bone‐resorbing activity , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.